Nnwale Influenza Ag A+B
Nkọwa ngwa ngwa
Aha ngwaahịa: Influenza Ag A+B Test
Ihe atụ: imi/Nasopharyngeal swab
Ụdị diluent: ebubu ụzọ
Onye na-ebu: tube (400ul)
Nchọpụta: FLU A+B
Ozi ngosi
Asambodo nsọpụrụ
Nkọwapụta Ụlọ ọrụ
Anyị, Hangzhou Testsea Biotechnology Co., Ltd bụ ụlọ ọrụ ọkachamara biotechnology na-eto ngwa ngwa ọkachamara na nyocha, mmepe, nrụpụta na nkesa nke ngwa ule in-vitro diagnostics (IVD) dị elu na ngwa ahụike.
Ụlọ ọrụ anyị bụ GMP, ISO9001, na ISO13458 kwadoro ma anyị nwere nkwenye CE FDA.Ugbu a, anyị na-atụ anya isonyere ọtụtụ ụlọ ọrụ esenidụt maka mmepe otu.
Anyị na-emepụta ule ọmụmụ, ule ọrịa na-efe efe, ule iji ọgwụ ọjọọ eme ihe, ule akara obi, ule akara tumor, ule nri na nchekwa na ule ọrịa anụmanụ, na mgbakwunye, akara TESTSEALABS bụ nke ama ama n'ahịa ụlọ na mba ofesi.Ogo kachasị mma na ọnụ ahịa dị mma na-enyere anyị aka iweghara 50% nke oke ụlọ.
ONkwakọ ngwaahịa & Mbupu
FAQ
Anyị dabeere na Zhejiang, China, malite na 2015, na-ere na Southeast Asia (15.00%), Domestic Market (15.00%), South, America (10.00%), Africa (10.00%), North America (5.00%), Eastern
Europe (5.00%), Oceania (5.00%), Mid East (5.00%), Eastern Asia (5.00%), Western Europe (5.00%), Central America (5.00%), Northern Europe (5.00%), Ndịda Europe ( 5.00%), Ndịda Eshia (5.00%).Enwere ihe dị ka mmadụ 51-100 na ụlọ ọrụ anyị.
Mgbe niile tupu mmepụta sample tupu uka mmepụta;
Nyocha ikpeazụ mgbe niile tupu mbupu;
Nnwale nyocha ngwa ngwa anụmanụ, ngwa ule ọmụmụ, ngwa ule ọgwụ ọjọọ ， Ngwa ule ọrịa na-efe efe ， Nnwale akara Tumor ， Nnwale nchekwa nri
Ike bara ụba na teknụzụ, akụrụngwa dị elu, sistemu njikwa ọgbara ọhụrụ, ngwa nyocha ngwa ngwa maka ụlọ ọgwụ, ezinụlọ na nyocha ụlọ nyocha, ISO, CE FSC asambodo.
Usoro nnyefe anabatara: FOB, CIF, EXW, FCA, DDP, nnyefe Express;
Ego ịkwụ ụgwọ anabatara: USD;RMB
Ụdị ịkwụ ụgwọ anabatara: T/T, Western Union, Escrow;
Asụsụ Asụsụ: Bekee
